Matthew Mossanen MD, MPH
Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, MassachusettsDr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and he received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.
His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer
Recent Contributions to PracticeUpdate:
- Use of BCG in Non-Muscle-Invasive Bladder Cancer
- Robotic Cystectomy in Bladder Cancer
- Optimizing Staging in Bladder Cancer
- Neoadjuvant Therapy for Locally Advanced Prostate Cancer
- Durvalumab as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
- Sorafenib vs Observation Following Radical Metastasectomy for Clear-Cell Renal Cell Carcinoma
- Optimal Sequence of Therapies for Bladder Cancer
- Adjuvant Chemotherapy Versus Radiation Following Cystectomy for Bladder Cancer
- Cytoreductive Surgery Along With Immunotherapy for Patients With Metastatic Renal Cell Carcinoma
- Patient Reported Experience for Patients With Renal Cell Carcinomas